Skip to main content
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,709.30
+9.50 (0.56%)
May 30, 2025, 9:30 AM IST

NSE:SUNPHARMA Revenue

In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B INR with 8.42% growth. Sun Pharmaceutical Industries had revenue of 129.59B in the quarter ending March 31, 2025, with 8.14% growth.

Revenue
525.78B
Revenue Growth
+8.42%
P/S Ratio
7.76
Revenue / Employee
12.23M
Employees
43,000
Market Cap
4,078.39B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Divi's Laboratories 93.60B
Cipla 271.45B
Mankind Pharma 122.07B
Apollo Hospitals Enterprise 211.46B
Zydus Lifesciences 232.42B
Aurobindo Pharma 317.24B
Alkem Laboratories 127.57B
Fortis Healthcare 77.83B
Revenue Rankings

Sun Pharmaceutical Industries News

More News